Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Haleon plc American Depositary Shares (Each representing two)

In a report released today, Ken Worthington from J.P. Morgan maintained a Buy rating on Hamilton Lane, with a price target of $149.00. According to...

Hamilton Lane (HLNE) Receives a Buy from J.P. Morgan

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bio-Rad Laboratories (BIO) and Haleon PLC Sponsore...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO) and Haleon PLC Sponsored ADR (HLN)

Hamilton Lane Inc (HLNE) has disclosed a new risk, in the Regulation category. Hamilton Lane Inc. faces heightened regulatory complexity because so...

Regulatory Constraints on Evergreen Funds Pose Profitability Risks for Hamilton Lane Inc.

There’s a lot to be optimistic about in the Financial sector as 3 analysts just weighed in on Nuveen Churchill Direct Lending Corp. (NCDL), Hamilto...

Analysts’ Top Financial Picks: Nuveen Churchill Direct Lending Corp. (NCDL), Hamilton Lane (HLNE)

Haleon PLC ( ($GB:HLN) ) has provided an update. Haleon has repurchased 8,316,688 ordinary shares for cancellation under its ongoing buyback progra...

Haleon Cancels Over 8.3 Million Shares in Ongoing Buyback

In a report released today, Kyle McPhee from ATB Cormark Capital Markets maintained a Buy rating on High Liner Foods, with a price target of C$19.5...

ATB Cormark Capital Markets Keeps Their Buy Rating on High Liner Foods (HLF)

In a report released yesterday, Ryland Conrad from RBC Capital maintained a Hold rating on High Liner Foods, with a price target of C$16.00. The co...

RBC Capital Remains a Hold on High Liner Foods (HLF)

An update from Haleon PLC ( ($GB:HLN) ) is now available. Haleon has published updated listing particulars for its £10 billion Euro Medium Term Not...

Haleon Updates Listing Particulars for £10bn EMTN Programme

Haleon PLC ( ($GB:HLN) ) has shared an update. Haleon plc has confirmed that, as of 30 April 2026, it has 8,891,932,595 issued ordinary shares, of ...

Haleon Updates Share Capital and Voting Rights for Disclosure Purposes

In a report released on April 29, Karel Zoete from Kepler Capital maintained a Buy rating on Haleon PLC, with a price target of p450.00. The compan...

Kepler Capital  Sticks to Its Buy Rating for Haleon PLC (HLN)

In a report released today, Olivier Nicolai from Goldman Sachs maintained a Buy rating on Haleon PLC, with a price target of p450.00. According to ...

Haleon PLC (HLN) Gets a Buy from Goldman Sachs

An announcement from Haleon PLC ( ($GB:HLN) ) is now available. Haleon plc reported the voting results of its 2026 annual general meeting, where sh...

Haleon Shareholders Back All Resolutions at 2026 AGM, Endorsing Board and Capital Flexibility

Barclays analyst Warren Ackerman maintained a Buy rating on Haleon PLC today and set a price target of £4.15. According to TipRanks, Ackerman is an...

Market Cap	$40.33B	P/E Ratio	16.50
52W High	$11.42	52W Low	$8.71
Div Yield	26.1%	Payout Ratio	N/A
EPS Growth 3Y	2.2%	52W Position	19.6%
Overall Score	24	Value Score	--
Quality Score	21	Technical Score	27

EPS Current Est	$0.56	EPS Next Est	$0.6
EPS Growth Est	+7.1%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HLN	$9.24	-0.54%	10.02M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HLN	$9.24	-0.5%	10.02M
3
4
5
6

HLN

HLN

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Haleon plc American Depositary Shares (Each representing two) Data in Excel

Get Haleon plc American Depositary Shares (Each representing two) Data in Excel